The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer

systematic reviews registry database analyses and economic evaluation

C Robertson, S K Arcot Ragupathy, C Boachie, J M Dixon, C Fraser, R Hernández, S Heys, W Jack, G R Kerr, G Lawrence, G MacLennan, A Maxwell, J McGregor, G Mowatt, S Pinder, L Ternent, R E Thomas, L Vale, R Wilson, S Zhu & 1 others F J Gilbert

Research output: Contribution to journalArticle

47 Citations (Scopus)
4 Downloads (Pure)

Abstract

There are 45,000 new cases of breast cancer in the UK each year and approximately 25% of women develop a recurrence in the same breast or in the opposite breast. Many of these recurrences are found during the first 3 years after treatment. Recurrent breast cancer might be found by either mammography, clinical examination or by the patient. There is uncertainty about how best to detect a recurrence and about the frequency of follow-up of these women. This study proposes to use data, both from existing research and data already collected on the outcomes of women following treatment for primary breast cancer, to identify the most effective and efficient method of providing surveillance mammography for women who have previously been treated for primary breast cancer. This study will seek to identify how often the surveillance should be offered, whether this procedure is worthwhile, safety (as mammograms involve exposure to X-rays) and efficiency, i.e. balancing the costs of surveillance with the benefits to ensure that our limited health care resources are used in the best way they can.
Original languageEnglish
Pages (from-to)v-vi, 1-322
Number of pages322
JournalHealth Technology Assessment
Volume15
Issue number34
DOIs
Publication statusPublished - Aug 2011

Fingerprint

Mammography
Cost-Benefit Analysis
Registries
Databases
Breast Neoplasms
Recurrence
Breast
Health Resources
Therapeutics
Uncertainty
X-Rays
Delivery of Health Care
Safety
Costs and Cost Analysis
Research

Keywords

  • Adult
  • Breast Neoplasms
  • Cost-Benefit Analysis
  • Databases, Factual
  • Female
  • Great Britain
  • Health Care Surveys
  • Humans
  • Incidence
  • Magnetic Resonance Imaging
  • Mammography
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Prevalence
  • Quality-Adjusted Life Years
  • Registries
  • Risk Factors
  • Sensitivity and Specificity
  • Survival Analysis
  • Ultrasonography

Cite this

The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer : systematic reviews registry database analyses and economic evaluation. / Robertson, C; Arcot Ragupathy, S K; Boachie, C; Dixon, J M; Fraser, C; Hernández, R; Heys, S; Jack, W; Kerr, G R; Lawrence, G; MacLennan, G; Maxwell, A; McGregor, J; Mowatt, G; Pinder, S; Ternent, L; Thomas, R E; Vale, L; Wilson, R; Zhu, S; Gilbert, F J.

In: Health Technology Assessment, Vol. 15, No. 34, 08.2011, p. v-vi, 1-322.

Research output: Contribution to journalArticle

Robertson, C ; Arcot Ragupathy, S K ; Boachie, C ; Dixon, J M ; Fraser, C ; Hernández, R ; Heys, S ; Jack, W ; Kerr, G R ; Lawrence, G ; MacLennan, G ; Maxwell, A ; McGregor, J ; Mowatt, G ; Pinder, S ; Ternent, L ; Thomas, R E ; Vale, L ; Wilson, R ; Zhu, S ; Gilbert, F J. / The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer : systematic reviews registry database analyses and economic evaluation. In: Health Technology Assessment. 2011 ; Vol. 15, No. 34. pp. v-vi, 1-322.
@article{bbfa5d9ca65b486a91043b7a7bfce27f,
title = "The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation",
abstract = "There are 45,000 new cases of breast cancer in the UK each year and approximately 25{\%} of women develop a recurrence in the same breast or in the opposite breast. Many of these recurrences are found during the first 3 years after treatment. Recurrent breast cancer might be found by either mammography, clinical examination or by the patient. There is uncertainty about how best to detect a recurrence and about the frequency of follow-up of these women. This study proposes to use data, both from existing research and data already collected on the outcomes of women following treatment for primary breast cancer, to identify the most effective and efficient method of providing surveillance mammography for women who have previously been treated for primary breast cancer. This study will seek to identify how often the surveillance should be offered, whether this procedure is worthwhile, safety (as mammograms involve exposure to X-rays) and efficiency, i.e. balancing the costs of surveillance with the benefits to ensure that our limited health care resources are used in the best way they can.",
keywords = "Adult, Breast Neoplasms, Cost-Benefit Analysis, Databases, Factual, Female, Great Britain, Health Care Surveys, Humans, Incidence, Magnetic Resonance Imaging, Mammography, Middle Aged, Neoplasm Recurrence, Local, Prevalence, Quality-Adjusted Life Years, Registries, Risk Factors, Sensitivity and Specificity, Survival Analysis, Ultrasonography",
author = "C Robertson and {Arcot Ragupathy}, {S K} and C Boachie and Dixon, {J M} and C Fraser and R Hern{\'a}ndez and S Heys and W Jack and Kerr, {G R} and G Lawrence and G MacLennan and A Maxwell and J McGregor and G Mowatt and S Pinder and L Ternent and Thomas, {R E} and L Vale and R Wilson and S Zhu and Gilbert, {F J}",
note = "Final Report Submitted to NIHR HTA Programme",
year = "2011",
month = "8",
doi = "10.3310/hta15340",
language = "English",
volume = "15",
pages = "v--vi, 1--322",
journal = "Health Technology Assessment",
issn = "1366-5278",
publisher = "National Co-ordinating Centre for HTA",
number = "34",

}

TY - JOUR

T1 - The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer

T2 - systematic reviews registry database analyses and economic evaluation

AU - Robertson, C

AU - Arcot Ragupathy, S K

AU - Boachie, C

AU - Dixon, J M

AU - Fraser, C

AU - Hernández, R

AU - Heys, S

AU - Jack, W

AU - Kerr, G R

AU - Lawrence, G

AU - MacLennan, G

AU - Maxwell, A

AU - McGregor, J

AU - Mowatt, G

AU - Pinder, S

AU - Ternent, L

AU - Thomas, R E

AU - Vale, L

AU - Wilson, R

AU - Zhu, S

AU - Gilbert, F J

N1 - Final Report Submitted to NIHR HTA Programme

PY - 2011/8

Y1 - 2011/8

N2 - There are 45,000 new cases of breast cancer in the UK each year and approximately 25% of women develop a recurrence in the same breast or in the opposite breast. Many of these recurrences are found during the first 3 years after treatment. Recurrent breast cancer might be found by either mammography, clinical examination or by the patient. There is uncertainty about how best to detect a recurrence and about the frequency of follow-up of these women. This study proposes to use data, both from existing research and data already collected on the outcomes of women following treatment for primary breast cancer, to identify the most effective and efficient method of providing surveillance mammography for women who have previously been treated for primary breast cancer. This study will seek to identify how often the surveillance should be offered, whether this procedure is worthwhile, safety (as mammograms involve exposure to X-rays) and efficiency, i.e. balancing the costs of surveillance with the benefits to ensure that our limited health care resources are used in the best way they can.

AB - There are 45,000 new cases of breast cancer in the UK each year and approximately 25% of women develop a recurrence in the same breast or in the opposite breast. Many of these recurrences are found during the first 3 years after treatment. Recurrent breast cancer might be found by either mammography, clinical examination or by the patient. There is uncertainty about how best to detect a recurrence and about the frequency of follow-up of these women. This study proposes to use data, both from existing research and data already collected on the outcomes of women following treatment for primary breast cancer, to identify the most effective and efficient method of providing surveillance mammography for women who have previously been treated for primary breast cancer. This study will seek to identify how often the surveillance should be offered, whether this procedure is worthwhile, safety (as mammograms involve exposure to X-rays) and efficiency, i.e. balancing the costs of surveillance with the benefits to ensure that our limited health care resources are used in the best way they can.

KW - Adult

KW - Breast Neoplasms

KW - Cost-Benefit Analysis

KW - Databases, Factual

KW - Female

KW - Great Britain

KW - Health Care Surveys

KW - Humans

KW - Incidence

KW - Magnetic Resonance Imaging

KW - Mammography

KW - Middle Aged

KW - Neoplasm Recurrence, Local

KW - Prevalence

KW - Quality-Adjusted Life Years

KW - Registries

KW - Risk Factors

KW - Sensitivity and Specificity

KW - Survival Analysis

KW - Ultrasonography

U2 - 10.3310/hta15340

DO - 10.3310/hta15340

M3 - Article

VL - 15

SP - v-vi, 1-322

JO - Health Technology Assessment

JF - Health Technology Assessment

SN - 1366-5278

IS - 34

ER -